Interpharma Pty Ltd v Commissioner of Patents [2008] FCA 1283
Interpharma had no reasonable prospect of succeeding on its s 52 Trade Practices Act claim because Lilly's alleged representations to the Commissioner in seeking a statutory extension of patent term were not made in trade or commerce. Although the Court was not satisfied that Interpharma had no reasonable prospect on standing, it had no reasonable prospect of prosecuting the ADJR Act, s 192 Patents Act and s 39B Judiciary Act claims because its delay in challenging the extension was unreasonable. As those claims would not proceed, the proposed amendments were pointless.
- Jurisdiction
- Australia
- Judgment Date
- 21 August 2008
- Procedural Posture
- Patent, Administrative Law and Trade Practices Act Proceeding / Interlocutory Motions: Application by Lilly for Dismissal Under S 31 a of the Federal Court of Australia Act 1976 (cth), and Application by Interpharma for Leave to Amend
- Outcome
- Lilly's s 31A dismissal motion succeeded as to the challenged claims; Interpharma's amendment motion was dismissed; Interpharma was ordered to pay the first respondent's costs of the motions specified.
- Legal Topics
- ['misleading and Deceptive Conduct in Trade or Commerce' 'extension of Patent Term' 'standing as a Person Aggrieved' 'delay in Judicial Review Proceedings' 'summary Judgment' 'rectification of Register of Patents']
Case Brief
Summary, issues, holding and outcome
More case intelligence is available
Unlock the full research layer for this judgment.
Procedural Posture
Patent, Administrative Law and Trade Practices Act Proceeding / Interlocutory Motions: Application by Lilly for Dismissal Under S 31 a of the Federal Court of Australia Act 1976 (cth), and Application by Interpharma for Leave to Amend
Legal Issues
- 1 ['Whether alleged representations in an application to the Commissioner of Patents for extension of patent term were made in trade or commerce for the purposes of s 52 of the Trade Practices Act 1974 (Cth).' 'Whether Interpharma had standing as a person aggrieved to seek ADJR Act review, rectification under s 192 of the Patents Act 1990 (Cth), and relief under s 39B of the Judiciary Act 1903 (Cth).' 'Whether Interpharma should be denied relief because of delay in instituting proceedings challenging the extension of term.' 'Whether Interpharma should have leave to amend its Amended Application and Amended Statement of Claim.']
Ratio Decidendi
Interpharma had no reasonable prospect of succeeding on its s 52 Trade Practices Act claim because Lilly's alleged representations to the Commissioner in seeking a statutory extension of patent term were not made in trade or commerce. Although the Court was not satisfied that Interpharma had no reasonable prospect on standing, it had no reasonable prospect of prosecuting the ADJR Act, s 192 Patents Act and s 39B Judiciary Act claims because its delay in challenging the extension was unreasonable. As those claims would not proceed, the proposed amendments were pointless.
Court Disposition
Lilly's s 31A dismissal motion succeeded as to the challenged claims; Interpharma's amendment motion was dismissed; Interpharma was ordered to pay the first respondent's costs of the motions specified.
Orders
- ['Paragraphs 1 to 6, 8 and 10 of the Amended Application and paragraphs 7 to 19 of the Amended Statement of Claim be dismissed pursuant to s 31A of the Federal Court of Australia Act 1976 (Cth).' "The applicant's motion notice of which was filed on 22 July 2008 be dismissed." "The applicant pay the first...
Full Case Text
Judgment text and source record
Sign in to read
Sign in to read the full judgment text
Sign in to read the full judgment text. Downloads and additional research tools may depend on your plan.
Sign in to read the full judgment